Hartford Hospital, Hartford, CT, USA.
Harvard Medical School, Boston, MA, USA.
Heart Fail Rev. 2018 Sep;23(5):701-709. doi: 10.1007/s10741-018-9715-y.
Congestive heart failure (CHF) is the most common cause of hospital admission in the USA costing the taxpayers billions of dollars. Sleep-disordered breathing (SDB) is a common co-morbid condition associated with CHF with prevalence estimated to be 60-70%. Despite substantial evidence supporting the negative impact of SDB on CHF, the condition is underrecognized and undertreated. Patients admitted to the hospital with CHF and SDB are prime candidates for intervention with positive airway pressure (PAP) therapy as they form a "captive audience," and timely intervention and education may mitigate sub-optimal outcomes. In conclusion, this review explores emerging data on the cost effectiveness and outcome of early intervention with PAP in hospitalized CHF patients.
充血性心力衰竭（CHF）是美国最常见的住院原因，纳税人为此花费了数十亿美元。睡眠呼吸障碍（SDB）是一种常见的合并症，与 CHF 相关，其患病率估计为 60-70%。尽管有大量证据支持 SDB 对 CHF 的负面影响，但该病症的识别和治疗不足。因 CHF 和 SDB 住院的患者是接受气道正压通气（PAP）治疗干预的主要候选者，因为他们形成了“被锁定的受众”，及时的干预和教育可能会改善不理想的结果。总之，本综述探讨了早期 PAP 干预对住院 CHF 患者的成本效益和结果的新数据。
